National News Release November 5, 1999 CONTACT: Bill
Wright PHONE: (202) 693-1999
Stresses employer use of new medical advances
OSHA REVISES BLOODBORNE PATHOGENS COMPLIANCE
DIRECTIVE
A new directive issued today by the Occupational Safety and
Health Administration will help minimize serious health risks faced
by workers exposed to blood and other potentially infectious
materials. Among the risks are human immunodeficiency virus (HIV),
hepatitis B and hepatitis C.
The directive guides OSHA's compliance officers in enforcing the
standard that covers occupational exposure to bloodborne pathogens
and ensures consistent inspection procedures are followed. It
updates an earlier directive issued in 1992 and reflects the
availability of improved devices, better treatment following
exposure and OSHA policy interpretations.
"We must do everything we can to protect workers who may be at
risk of exposure to bloodborne diseases," said Secretary of Labor
Alexis M. Herman. "This directive doesn't place new requirements on
employers, but it does recognize and emphasize the advances made in
medical technology. And it reminds employers that they must use
readily-available technology in their safety and health
programs."
The revised directive emphasizes the importance of an annual
review of the employer's bloodborne pathogens program and the use of
safer medical devices to help reduce needlesticks and other sharps
injuries. OSHA does not advocate the use of one particular medical
device over another. The directive also highlights basic work
practices, personal protective equipment and administrative
controls.
The emphasis on engineering controls results from OSHA's request
last year for ideas and recommendations on ways to better protect
workers from contaminated needles or other sharp objects.
"We received nearly 400 comments from health care facilities,
workers and others," said OSHA Administrator Charles N. Jeffress.
"They told us that safe medical devices already available are
effective in controlling hazards and that wider use of such devices
would reduce thousands of injuries each year."
The revised directive also includes detailed instructions to
compliance officers on inspections of multi-employer worksites, such
as home health services, employment agencies, personnel services,
physicians and health care professionals in independent practices,
and independent contractors.
Also included in the directive are decontamination requirements,
guidelines on hepatitis vaccinations and post exposure treatments,
and employee training.
OSHA issued a final regulation on occupational exposure to
bloodborne pathogens in 1991 to protect nearly six million workers
in health care and related occupations at risk of exposure to
bloodborne diseases. Jeffress said the agency will review the
standard to determine whether its revision is warranted.
The directive can be accessed from the OSHA home page at (http://www.osha.gov)
under the "Directives" link. Copies can also be obtained from the
agency's Publications Office by calling (202) 693-1888. (NOTE: A
fact sheet providing highlights of the revised directive follows
this release).
# # #
The text of this news release is on the Internet World Wide Web
at http://www.osha.gov/index.html.
Information on this news release will be made available to sensory
impaired individuals upon request. Voice phone: (202) 693-1999.
Highlights of OSHA's Compliance Directive CPL
2-2.44D Enforcement Procedures for the Occupational
Exposure to Bloodborne Pathogens
OSHA first published the bloodborne pathogens standard in 1991
because of a significant health risk associated with occupational
exposure to blood and other potentially infectious materials that
may contain bloodborne pathogens-- or microorganisms -- that cause
bloodborne diseases. The compliance directive detailing enforcement
procedures for the standard was published on March 6, 1992 (the
effective date of the standard).
During the past seven years, significant medical advances have
occurred that help control bloodborne pathogens. In addition, OSHA
has clarified the standard through written interpretations. The
emerging technology, coupled with new information on the control of
bloodborne pathogens, necessitated a revision in the compliance
directive. Following is a summary of some of the key revisions.
- Annual Review of Exposure Control Plan -- employers must
ensure that their plans reflect consideration and use of
commercially available safer medical devices.
- Engineering Controls and Work Practices -- emphasizes the use
of effective engineering controls, to include safer medical
devices, work practices, administrative controls and personal
protective equipment.
- Emphasizes that employers should rely on relevant evidence in
addition to FDA approval to ensure effectiveness of devices
designed to prevent exposure to bloodborne pathogens.
- Multi-Employer Worksites -- focuses on employment agencies,
personnel services, home health services, independent contractors,
and physicians in independent practice.
- Adds most recent guidelines from the Centers for Disease
Control on vaccinations against the Hepatitis B virus.
Incorporates CDC's guidelines on post exposure evaluation and
follow-up for HIV and the Hepatitis C virus.
- Requires effective training and education for employees
whenever safer devices are implemented. Stresses "interactive"
training sessions rather than just the use of films or videos that
do not provide the opportunity for discussion with a qualified
trainer.
- Replaces and updates appendices. Includes the following:
examples of committees in health care facilities; sample
engineering control evaluation forms; an Internet resource list; a
"fill-in-the-blanks" sample exposure control plan; and CDC
guidelines pertaining to HIV exposure, control and prevention of
hepatitis C, and hepatitis B vaccinations..
| USDOL | CONTACT
INFORMATION | DISCLAIMER
|
|